Impact of tetrapeptide pancragen on endocrine function of the pancreas in old monkeys
Animal research · 2014
- What was studied
- Old female rhesus monkeys; younger comparison animals
- Main finding
- Reports glucose-clearance and insulin/C-peptide changes after treatment, with some changes persisting after withdrawal.
Insulin/C-peptide peak timing · 5 and 15 minutes after glucose in baseline experiments
Reported findings and study design
Older female rhesus monkeys; Pancragen 50 micrograms/animal/day IM for ten days; glucose-tolerance measurements.
Population or model Old female rhesus monkeys; younger comparison animals
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Insulin/C-peptide peak timing | 5 and 15 minutes after glucose in baseline experiments | |
| Persistence of reported pancreatic response | Partly maintained three weeks after treatment stopped | |
| Treatment effect magnitude | Not numerically quantified in abstract |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Non-human primates; no human efficacy or safety conclusion follows.
- Full methods, adverse-event reporting and independent replication remain to be appraised.
Source details
Journal publication
Europe PMC indexed citation and abstract checked. Full original paper not reviewed.
Sources checked
Citation
Goncharova ND, Ivanova LG, Oganian TÉ, Vengerin AA, Khavinson VKh. Impact of tetrapeptide pancragen on endocrine function of the pancreas in old monkeys Advances in gerontology = Uspekhi gerontologii 27(4):662-667. PMID 25946840